Halotestex Tablets
Halotestex Tablets British Dragon — Overview
Halotestex Tablets deliver fluoxymesterone at 10 mg per tablet — one of the most androgenic oral AAS in use, known commercially as Halotestin. Fluoxymesterone occupies a narrow but well-defined role in performance protocols: it does not build significant mass, does not aromatize, and is not suited for extended cycles. What it does — specifically and reliably — is drive strength output, aggression, and CNS activation over short windows of four to six weeks, making it a tool for powerlifters peaking for a competition, pre-contest bodybuilders in the final weeks of a cut, and combat sports athletes during training camp.
The compound's highly hepatotoxic profile from 17α-alkylation means strict cycle length limits and liver support throughout. Used within these constraints, Halotestex from Steroid Warehouse delivers the fluoxymesterone profile in British Dragon's standard manufacturing format — a specific compound for specific goals.
About the Compound
Fluoxymesterone is a synthetic testosterone derivative carrying three structural modifications: a 9α-fluorine atom, an 11β-hydroxyl group, and a 17α-methyl group. The 17α-methyl allows oral bioavailability but introduces hepatotoxicity. The 9α-fluoro and 11β-hydroxy substitutions dramatically increase androgenic potency by enhancing androgen receptor binding affinity while simultaneously blocking aromatization — fluoxymesterone does not convert to estrogen at any clinically relevant dose.
The result is a compound with an androgenic potency approximately 19 times that of testosterone by receptor binding metrics, no estrogenic activity, and a plasma half-life of approximately nine hours. The short half-life requires splitting the daily dose into two or three administrations to maintain consistent blood levels. Fluoxymesterone also binds sex hormone-binding globulin (SHBG) with high affinity, which can elevate free testosterone fractions when co-administered with a testosterone base.
The primary mechanism responsible for its strength-without-mass effect is CNS-mediated: fluoxymesterone increases neuromuscular drive and aggression through central androgen receptor activation, producing strength gains that outpace corresponding mass accumulation. This distinguishes it from anabolic-dominant compounds where strength gains track lean tissue growth more closely.
What Halotestex Does
Fluoxymesterone produces a narrow, high-intensity effect profile compared to most AAS. Its effects are primarily neurological and androgenic rather than anabolic in the tissue-building sense:
- Strength output — the compound's primary application. CNS androgen receptor activation increases neuromuscular recruitment, motor unit firing rate, and training aggression. Strength gains of 10–20% over a four-week run are reported in strength-sport contexts, with minimal corresponding mass gain.
- Aggression and drive — heightened competitive aggression, focus, and pain tolerance during training. This effect is reliable and pronounced; it is also the primary reason fluoxymesterone is used in combat sports training camps where psychological readiness matters as much as physical output.
- Hardness and density — in pre-contest conditions with low body fat, fluoxymesterone adds a visual hardness to musculature. Without water retention or estrogen-driven subcutaneous fluid, the result at contest condition can be pronounced.
- SHBG displacement — strong SHBG binding frees up a larger fraction of circulating testosterone when co-administered with a testosterone base, effectively increasing the bioactive testosterone available during the cycle.
- Erythropoietic stimulation — androgenic compounds including fluoxymesterone stimulate red blood cell production, contributing to endurance and recovery capacity during short peak cycles.
What Halotestex does not do: it does not build significant lean mass. Users expecting a mass-building oral from fluoxymesterone will be disappointed — this is the wrong tool for that goal. The compound's value is entirely in strength, aggression, and pre-contest hardening over a short, defined window.
Who It Is For
Fluoxymesterone is a specialist compound — it performs one role extremely well and is poorly suited to everything else. It belongs in the protocols of experienced users with a specific performance objective and an existing understanding of their own response to androgenic compounds.
It is most appropriate for:
- Competitive powerlifters peaking for a meet — fluoxymesterone added in the final four weeks of a strength cycle produces measurable increases in maximal strength output without meaningfully changing body weight, which matters for weight-class sports.
- Pre-contest bodybuilders in the final four to five weeks who need both aggression to push through depleted training and visual hardness at low body fat without the water retention risk of aromatizing compounds.
- Combat sports athletes in training camp who want a legal-in-training aggression and drive boost — the CNS activation effect makes it attractive for high-intensity training phases.
Choose something else when: lean mass is the primary goal (fluoxymesterone builds strength, not size — use a testosterone base with nandrolone or boldenone instead); when liver function is compromised or a previous cycle included hepatotoxic orals without a recovery interval; when the cycle needs to run longer than six weeks; or when androgenic side effects — acne, hair, aggression management — are already a concern at baseline. For dry conditioning without the hepatotoxic profile, Stanabol Tablets BD is a more forgiving alternative at the cost of the CNS drive effect.
Halotestex vs Alternatives
| Compound | Key Differences | Choose Halotestex When | Choose Alternative When |
|---|---|---|---|
| Halotestex British Dragon |
Fluoxymesterone; highly androgenic; strong CNS drive; no aromatization; 4–6 wk max; hepatotoxic; 17α-methylated; ~9h half-life | Peak strength output; aggression for competition or training camp; pre-contest hardness; weight-class athletes | — |
| Stanabol Tablets British Dragon |
Stanozolol; DHT-derived; less androgenic potency; no water retention; longer cycles possible (6–8 wks); also hepatotoxic; joint drying effect; no CNS aggression drive | Dry conditioning without the intensity of fluoxymesterone aggression; slightly longer cycle acceptable; joint tolerance is not an issue | Peak strength output and CNS drive are the primary goals; weight-class strength sport → Halotestex |
| Trenabol 100 British Dragon |
Trenbolone phenylpropionate; injectable; stronger overall anabolic + androgenic effect; hardening + conditioning + strength; no liver toxicity from 17α-alkylation; longer cycle possible; more complex side profile (tren cough, prolactin, night sweats) | Oral-only preference; weight-class sport (injection-free); short window of 4 wks maximum | Mass + strength + conditioning goal with injectable preference; no hard cycle-length limit → Trenabol 100 |
Combinations
| Goal | Stack | Why It Works |
|---|---|---|
| Powerlifting peak (strength-only) | Halotestex (20–30 mg/day, weeks 1–4) + Testabol Enanthate (400–500 mg/wk base throughout) |
Testosterone base prevents androgen deficiency symptoms while fluoxymesterone drives CNS strength output. The enanthate ester runs the full cycle; Halotestex is added for the four-week peak window preceding competition. Classic powerlifting protocol structure. |
| Pre-contest hardening (final 4–5 weeks) | Halotestex (10–20 mg/day, final 4 wks) + Testabol Propionate (300–400 mg/wk) + Mastabol 100 (300 mg/wk) |
Three dry, non-aromatizing compounds. Masteron adds hardness and mild anti-estrogenic character; Halotestex drives aggression through the depleted pre-contest training phase. No water retention risk from any component. |
| Combat sports training camp | Halotestex (10–20 mg/day, 4 wks) + Testabol Propionate (200–300 mg/wk) |
Low testosterone base to maintain androgen tone; fluoxymesterone provides the aggression and drive effect for high-intensity camp training. Kept at the lower dose range to manage androgenic side effects during extended daily training volume. |
Side Effects & Management
Halotestex carries a demanding side effect profile dominated by hepatotoxicity and androgenic effects. This is not a compound that forgives poor cycle management — the risks are real and dose- and duration-dependent.
| What May Occur | Background | How to Handle It |
|---|---|---|
| Hepatotoxicity (primary concern) | 17α-methylation prevents hepatic first-pass degradation but places direct metabolic stress on liver cells. Fluoxymesterone is among the more hepatotoxic oral AAS at standard doses. Liver enzyme elevation (AST, ALT) begins within the first week and is universal at doses above 20 mg/day. | Liv52 herbal liver support throughout the entire run. Keep cycles to four weeks at higher doses (20–30 mg/day) or six weeks at 10 mg/day. Alcohol is contraindicated. Do not stack with other 17α-alkylated orals. Run liver function panel before, mid-cycle, and after. |
| Androgenic effects (acne, hair) | Fluoxymesterone's high androgenic potency drives sebaceous activity and accelerates androgenetic alopecia in predisposed users. The 9α-fluoro substitution blocks 5α-reduction, so finasteride is ineffective — the compound is already more androgenic than its 5α-reduced metabolite would be. | Persistent cystic acne: Isotroin (isotretinoin). Hair loss in predisposed users cannot be pharmacologically mitigated with standard 5-alpha reductase inhibitors — this is a structural property of the molecule. |
| LDL elevation / HDL suppression | Non-aromatizing androgens suppress HDL more aggressively than aromatizing compounds. Fluoxymesterone at standard doses produces significant adverse lipid shifts. The combination with hepatic stress makes lipid management particularly important. | Lipid panel at baseline and mid-cycle (week 2–3). Elevated LDL: Atorlip (atorvastatin). Omega-3 supplementation and cardiovascular training are standard adjuncts. |
| Blood pressure elevation | Erythropoietic stimulation increases red blood cell mass and blood viscosity. Combined with the cardiovascular lipid impact, BP monitoring is warranted particularly on higher doses. | Monitor BP weekly. Sustained readings above 135/85 mmHg: Amlip (amlodipine) 5 mg/day. Adequate hydration and maintained aerobic capacity reduce baseline BP elevation risk. |
| Aggression / mood intensity | The CNS androgenic drive that makes fluoxymesterone effective for competition also produces pronounced mood intensity and irritability in some users. This effect is dose-dependent and resolves within days of discontinuation. | Dose at the lower end (10–20 mg/day) if aggression is unmanageable outside the competitive context. The compound is not appropriate for users with anger management concerns at baseline. |
| HPG axis suppression | Fully suppressive at any meaningful dose. Endogenous testosterone production ceases during the cycle and requires structured PCT to recover. | Mandatory PCT. See section below. |
Bloodwork Monitoring
| Lab | When to Test | Target & Action Threshold |
|---|---|---|
| Liver enzymes (AST / ALT) | Baseline; week 2–3 (mid-cycle); end of cycle; 3–4 weeks post-cycle | Elevation up to 2–3× upper limit of normal (ULN) is common on fluoxymesterone. Above 3× ULN: reduce dose or stop. Above 5× ULN: discontinue immediately. Continue Liv52 until enzymes normalize post-cycle. |
| Lipid panel (HDL / LDL) | Baseline; week 2–3 | HDL above 35 mg/dL; LDL below 130 mg/dL. Adverse shifts are expected — add Atorlip if LDL exceeds threshold. Omega-3 supplementation throughout. Re-test 4 weeks post-cycle to confirm recovery. |
| Hematocrit / CBC | Baseline; end of cycle | Keep hematocrit below 52%. Given the short 4–6 week cycle, significant elevation is less common than on longer protocols, but should be confirmed especially if stacked with injectable testosterone. |
| Blood pressure | Weekly throughout cycle | Target below 130/80 mmHg. Sustained elevation above 140/90: add Amlip. Limit sodium; maintain aerobic training output. |
| LH + FSH | 3–4 weeks post-PCT | Recovery to normal range confirms HPG axis restart. After a 4–6 week fluoxymesterone cycle, recovery is typically faster than after longer suppressive protocols. |
| Total testosterone | 3–4 weeks post-PCT | Return to pre-cycle baseline. If suppressed at 8–10 weeks post-PCT after a short cycle, further evaluation is warranted. |
PCT — Post-Cycle Therapy
Fluoxymesterone clears rapidly given its ~9-hour half-life — PCT can begin approximately 24–48 hours after the final tablet. This is one of the few practical advantages of the short half-life: the recovery window opens immediately after stopping.
| Product | Role in PCT |
|---|---|
| Clomiphene Tablets BD | 50 mg/day weeks 1–2, then 25 mg/day weeks 3–4. Stimulates LH and FSH release at the pituitary level to drive testicular testosterone recovery. Start 24–48 hours after the last Halotestex tablet if no long-ester testosterone is in the stack; otherwise, time to the long ester's clearance window. |
| Tamoxifen Tablets BD | 20 mg/day weeks 1–2, then 10 mg/day weeks 3–4. Blocks estrogen at the hypothalamic receptor to restore GnRH pulse frequency. Running both SERMs together produces more reliable axis recovery than either alone. |
Liver enzymes during PCT: continue Liv52 through the PCT period and until a post-cycle liver panel confirms enzyme normalization. Fluoxymesterone's hepatic impact does not resolve at the moment of last dose — enzyme recovery typically takes two to four weeks post-cycle.
Practical Summary
- Four weeks is the practical maximum at 20–30 mg/day: hepatotoxicity is dose- and duration-dependent; six weeks is the outer limit only at the 10 mg/day entry dose. Exceeding these windows risks serious liver damage that outweighs any additional performance gain.
- Start Liv52 on day one, not after symptoms: liver support should be in place before the first tablet. Waiting for elevated enzymes before addressing hepatic load is the wrong approach with 17α-alkylated compounds.
- Split the dose 2–3× daily: the ~9-hour half-life means a single daily dose creates significant peaks and troughs. Morning/midday or morning/midday/evening splits maintain more consistent blood levels.
- Mandatory testosterone base: do not run fluoxymesterone without an exogenous testosterone base unless the cycle is literally a one-week peak-week protocol. Fully suppressive HPG effects with no testosterone replacement creates a low-androgen environment between fluoxymesterone CNS peaks.
- Liver enzymes before starting: anyone with pre-existing hepatic enzyme elevation should not use this compound. Baseline LFTs are non-negotiable, not optional, before starting a fluoxymesterone cycle.
- PCT starts 24–48 hours post-last-dose when not stacked with a long-ester base — the rapid clearance is the one area where fluoxymesterone's pharmacokinetics work in the user's favor.
Fluoxymesterone remains a specialist tool with a clearly defined use case: short, high-intensity strength and aggression windows for experienced athletes who have exhausted the ceiling of less demanding compounds. steroidwarehouse.com stocks Halotestex Tablets from British Dragon for users who understand the compound's specific role and the cycle discipline it requires — maximum four to six weeks, liver support throughout, and a clean PCT immediately after.
References
| Source | Description | Link |
|---|---|---|
| New England Journal of Medicine / PubMed | Bhasin et al. 1996 — randomized controlled trial using 600 mg/week testosterone enanthate for 10 weeks in healthy men; showed increased fat-free mass, muscle size, and strength, with the largest gains when supraphysiologic testosterone was combined with resistance training | Bhasin S, et al. (1996) ↗ |
| NCBI Bookshelf / StatPearls | Anabolic steroids overview — clinical reference on synthetic testosterone-derived anabolic-androgenic steroids, androgen receptor activity, medical uses, misuse patterns, oral and injectable AAS forms, monitoring concerns, and adverse effect profile | StatPearls: Anabolic Steroids ↗ |
| NCBI Bookshelf / Endotext | Androgen physiology and pharmacology — detailed medical overview of testosterone, dihydrotestosterone, androgen receptor signaling, aromatization to estradiol, HPG-axis regulation, synthetic androgen pharmacology, and androgen misuse context | Endotext: Androgen Physiology, Pharmacology, Use and Misuse ↗ |
| British Journal of Pharmacology / PubMed | Kicman AT 2008 — comprehensive review of anabolic steroid pharmacology; covers androgen receptor signaling, anabolic and androgenic mechanisms, steroid metabolism, structural modification, 17α-alkylated oral AAS, esterified injectable AAS, detection, and adverse effects | Kicman AT (2008) ↗ |
| Seminars in Liver Disease / PubMed | Ishak KG & Zimmerman HJ 1987 — review of hepatotoxic effects associated with anabolic-androgenic steroids; covers cholestatic liver injury, peliosis hepatis, hepatic adenoma, and hepatocellular carcinoma, with strongest relevance to 17α-alkylated oral AAS | Ishak KG & Zimmerman HJ (1987) ↗ |
What are Halotestex Tablets?
Halotestex Tablets are an oral anabolic steroid (Fluoxymesterone) for strength and aggression; see What are Halotestex Tablets. It's potent—consult professionals for safe use.
How long does Halotestex stay in your system?
Detectable for ~2 months; see How Long Does Halotestex Stay in Your System. Monitor with professional guidance.
What are Halotestex Tablets used for in bodybuilding?
They're used for strength, aggression, and muscle hardness pre-competition; see What are Halotestex Tablets Used For in Bodybuilding. They suit advanced users—use with oversight.
How to take Halotestex Tablets?
10-20 mg/day, taken pre-workout; see How to Take Halotestex Tablets. Start at 10 mg—consult professionals for dosing.
How do Halotestex Tablets work?
Fluoxymesterone works by strongly interacting with androgen receptors, promoting androgenic activity that can influence strength, power output, and performance characteristics.
How long does it take to notice effects from Halotestex Tablets?
As an oral compound, Halotestex Tablets are often associated with a relatively rapid onset, with users commonly reporting noticeable effects on training performance within a short period.
What are the main benefits of Halotestex Tablets?
Commonly discussed benefits include increased strength, enhanced training intensity, improved power output, and support for performance-focused athletic goals.
What are the possible side effects of Halotestex Tablets?
Potential side effects may include mood changes, increased aggression, acne, elevated blood pressure, liver stress, and suppression of natural testosterone production.
Related Products
